VALBIOTIS to begin trial of TOTUM-070 for LDL-cholesterol treatment
VALBIOTIS is set to initiate a Phase II HEART clinical study of TOTUM-070 for the...
VALBIOTIS is set to initiate a Phase II HEART clinical study of TOTUM-070 for the...
GenSight Biologics has reported that results from the Phase I/IIa REVEAL clinical trial of LUMEVOQ...
French biopharmaceutical firm Genkyotex has reported positive data from the Phase I trial of its...
Swiss biopharmaceutical firm Debiopharm has started the dosing of the first patient in a Phase...
Clinical stage biotechnology company Acticor Biotech has recruited the first patient in Phase II GARDEN...
France-based specialty vaccine company Valneva has commenced the Phase I/II VLA2001-201 clinical study of its...
Leading COVID-19 vaccine candidates from Pfizer/BioNTech (BNT-162b2) and Moderna (mRNA-1273) currently in Phase III trials...
Digital data capture technologies provider Kayentis has raised about $8.3m in growth capital in an...
Sanofi and Regeneron Pharmaceuticals have reported additional positive results from Part A of a Phase...
Sanofi’s vaccines global business unit Sanofi Pasteur and Translate Bio have reported preclinical trial results...